Welcome to our dedicated page for Envista Holdings news (Ticker: NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings stock.
Overview of Envista Holdings Corp
Envista Holdings Corp (NVST) is a globally recognized dental products company that delivers a comprehensive range of solutions specifically designed to meet the clinical and operational needs of dental professionals. With a robust portfolio covering dental implants, digital imaging systems, orthodontic products, and a broad range of dental consumables, Envista stands as a critical partner in enabling dental practices worldwide. The company integrates advanced technologies and innovative software, including AI-enhanced diagnostic tools and digital workflow solutions, to ensure precision, efficiency, and clear clinical outcomes in dental procedures. Industry-specific keywords such as dental implants, digital imaging, and AI-enhanced workflows are seamlessly woven into its offerings, reflecting Envista's commitment to technological innovation and continuous improvement.
Core Business Segments
Envista operates through two main segments:
- Specialty Products & Technologies: This division focuses on developing, manufacturing, and marketing advanced dental implant systems, regenerative solutions, orthodontic bracket systems and aligners, as well as associated lab products and digital treatment planning software. The emphasis is on creating a seamless integration of cutting-edge dental products that support a broad spectrum of patient care needs.
- Equipment & Consumables: This segment provides dental practices with essential consumable products and equipment needed for daily clinical operations. It supports diagnostic imaging, treatment planning, and procedural execution in dental practices, thereby reinforcing the end-to-end solution for dental care professionals.
Innovative Technologies and Business Methodology
Envista distinguishes itself by leveraging a unique blend of continuous improvement and a bias toward action underpinned by the proven Envista Business System (EBS). This methodology drives operational excellence and innovation, helping the company to adapt its product lines to evolving market needs and technological advancements. The incorporation of AI and digital workflow integration—such as enhanced intraoral scanning with guided workflows and predictive analytics—demonstrates its commitment to transforming traditional dental practices into digitally-enabled, efficient treatment centers.
Market Position and Global Reach
Envista maintains significant market positions in some of the most attractive segments of the dental products industry. Its portfolio is designed to cover nearly every aspect of a dental practice’s needs, from diagnostic imaging to therapeutic interventions. With a strong presence in North America and broad reach across Western Europe and other developed markets, Envista’s strategic approach has allowed it to serve diverse geographical regions while adhering to high-quality standards in dental care. This global footprint and diversified approach underscore its role as an essential player in dental care innovation and service.
Commitment to Dental Professionals and Community Impact
At its core, Envista is dedicated to empowering dental professionals by providing the right tools, technologies, and resources to create healthy, confident smiles. Its commitment extends beyond commercial success and includes philanthropic efforts through initiatives like the Envista Smile Project, which enhances access to oral health care in underserved communities. Such community-driven activities not only bolster the company's reputation but also underline its deeper belief in collaborative progress and societal improvement.
Business Model and Industry Relevance
Envista's business model is underpinned by the integration of advanced technology with a deep respect for clinical excellence. The company’s strategic investments in research, product development, and digital innovation position it uniquely within a competitive landscape that demands both precision and efficiency from dental care providers. By combining high-performance operational models with a rich portfolio of dental solutions, Envista remains essential for professionals striving to achieve superior patient outcomes. The company’s analytical approach and data-driven strategy are reflective of the modern trends in healthcare and digital transformation in dentistry.
Summary
In summary, Envista Holdings Corp is not just a supplier of dental products; it is a comprehensive, globally integrated partner that drives innovation and excellence in dental care. Its robust, multi-segment business model, advanced technological offerings, and commitment to dental professionals and community well-being illustrate its enduring relevance and depth of expertise in the dental industry.
Envista Holdings (NYSE: NVST) has announced it will release its first quarter 2025 financial results on Thursday, May 1, 2025. The company will host a conference call and webcast to discuss the results on the same day at 2:00 PM PT.
The one-hour earnings call will be accessible via phone (800-225-9448 within U.S., +1 203-518-9708 outside U.S.) using conference ID #3526593. A webcast with accompanying slide presentation will be available on the company's investor relations website, with materials posted before the call and a replay available for one year afterward.
DEXIS, a global dental imaging technology leader, has announced its participation in the International Dental Show (IDS) 2025 in Cologne, Germany. The company will showcase several innovations within its AI-powered digital ecosystem, including:
- Imprevo: A new high-performance intraoral scanner with rebuilt hardware and AI-powered algorithm
- IS ScanFlow 2.0: Updated software featuring a new Smile Visualizer tool for treatment previews
- ORTHOPANTOMOGRAPH OP 3D EX updates with new cephalometric imaging capabilities
- Automatic Dose Control feature for the ORTHOPANTOMOGRAPH OP 3D LX
- DTX Studio Clinic enhancements including automated implant planning, 3-minute surgical template generation, and upcoming AI-driven endodontic capabilities
The company will demonstrate these technologies at Hall 11.2 K050 L069, highlighting their integration into DEXIS's comprehensive digital workflow solution that currently has over 165,000 installations worldwide.
Envista Holdings (NYSE: NVST) announced that its Envista Smile Project contributed $1.8 million in 2024 to improve oral health accessibility for underserved communities. Since 2021, the project has provided over $4.2 million in dental goods and services, helping approximately 32,000 individuals globally.
Key 2024 achievements include:
- Provided free dental care to 787 patients in Dominican Republic
- Donated dental supplies to clinics serving over 5,600 patients
- Supplied portable x-ray access to multiple Mission of Mercy events
- Partnered with USC's Herman Ostrow School of Dentistry
- Sponsored five senior residents for Jamaica mission treating 1,661 patients
Envista Holdings (NYSE: NVST) reported Q4 2024 results with sales of $653 million and core sales growth of 2.0% compared to Q4 2023. The company achieved an Adjusted EBITDA margin of 13.9% and demonstrated improved performance in implants across Nobel Biocare, Implant Direct, and Alpha-Bio brands. Spark aligners showed continued market share gains and gross margin improvement.
Financial highlights include operating cash flow of $132 million and free cash flow of $124 million, representing increases of 30% and 24% respectively over Q4 2023. Q4 net income was $1 million ($0.01 per share), compared to a loss of $217 million in Q4 2023. For the full year 2024, the company reported a net loss of $1,119 million.
Looking ahead to 2025, Envista projects core sales growth of 1-3%, adjusted EBITDA margins of approximately 14%, and adjusted earnings per share between $0.95 and $1.05.
Envista Holdings (NYSE: NVST) has announced its upcoming Capital Markets Day, scheduled for Wednesday, March 5, 2025, from 9:00 a.m. to 12:00 p.m. EST. The event will feature a management presentation and a Q&A session.
In-person attendance will require advance registration through IR@envistaco.com. For those unable to attend physically, the event and presentation will be webcast and made available for replay on the Events and Presentations section of investors.envistaco.com.
DEXIS, a dental imaging technologies leader, reflects on its 2024 achievements and announces plans for 2025. Key 2024 launches included the DEXIS digital ecosystem for streamlined implant workflow, the Ti2 Intraoral Sensor with AI capabilities, DEXIS Connect Pro for proactive device monitoring, and the ORTHOPANTOMOGRAPH OP 3D EX X-ray platform.
The company plans several innovations for 2025, including their first in-house developed intraoral scanner, AI enhancements, 3D imaging portfolio expansion, and DTX Studio Clinic workflow updates. These developments will be showcased at the Chicago Dental Society Midwinter Meeting in February and the International Dental Show in Cologne in March. Currently, over 150,000 DEXIS dental imaging devices are in use worldwide.
Envista Holdings (NYSE: NVST) has announced its upcoming fourth quarter 2024 financial results release, scheduled for Wednesday, February 5, 2025. The company has rescheduled its conference call to 2:30 PM PT on the same date.
The one-hour earnings call will be accompanied by a slide presentation and webcast available on the 'Investors' section of Envista's website. Participants can join via phone by dialing 800-225-9448 (U.S.) or +1 203-518-9708 (international) using conference ID #7185081. The webcast replay will be accessible for one year, and related materials will be posted on the company's website prior to the call.
Envista Holdings (NYSE: NVST) has scheduled its fourth quarter 2024 earnings conference call for Wednesday, February 5, 2025, at 2:00 PM PT. The call will include a slide presentation and is expected to last approximately one hour.
Investors can access the webcast through the 'Investors' section of www.envistaco.com. A replay will be available for one year following the presentation. For direct dial-in access, participants can call 800-225-9448 (U.S.) or +1 203-518-9708 (international) using conference ID #7185081.
The earnings press release, webcast slides, and related materials will be posted on Envista's website before the conference call.
Envista Holdings (NYSE: NVST) has announced its upcoming participation in the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Wednesday, January 15, 2025, from 9:45 – 10:25 am PT at the Westin St. Francis Hotel in San Francisco. An audio-only recording of the presentation will be available on Envista's Investor Relations website for 30 days following the event.
DEXIS showcased its latest AI-powered solutions at the ADF conference in Paris, featuring new intraoral scanners and imaging products. The company presented its ORTHOPANTOMOGRAPH® OP 3D™ EX with customizable field of view and AI-powered software integration. The exhibition also highlighted the IS 3800W wireless scanner, offering ultra-fast impression capture and lightweight design. The company's expanded portfolio aims to enhance diagnostic workflows, increase productivity, and improve patient experience through innovative features like Oral Compare for treatment visualization and SmileFy integration for treatment simulations.
FAQ
What is the current stock price of Envista Holdings (NVST)?
What is the market cap of Envista Holdings (NVST)?
What is Envista Holdings Corp?
What are the main business segments of Envista?
How does Envista serve dental professionals?
What types of products does Envista offer?
What is the Envista Business System (EBS)?
How does Envista differentiate itself in the dental industry?
What role does innovation play in Envista's operations?
How is Envista involved in community support?
